STI Screening
Cross-source consensus on STI Screening from 1 sources and 3 claims.
1 sources · 3 claims
How it works
Comparisons
Highlighted claims
- Cancer survivors had modestly but significantly higher STI screening rates than cancer-free peers (24.8% vs 21.1%). — Gynaecological follow-up of adolescent and young adult cancer survivors: a comparative cohort study
- STI screening prevalence in the study cohort (31.1% receiving at least one screening) was substantially higher than the French national reference figures of 7% in 2016 and 12% in 2021 for the 15–25 age group. — Gynaecological follow-up of adolescent and young adult cancer survivors: a comparative cohort study
- Delays in reaching sexual milestones among cancer survivors may partially explain the smaller advantage survivors have in STI screening compared to their peers. — Gynaecological follow-up of adolescent and young adult cancer survivors: a comparative cohort study